Please read this first. This guide is a companion to your medical team, not a replacement, and it is
not medical advice.
Everything here is tied to published research. If something you expected is not here, it almost always means we have not mapped a source for it yet,
not that it is unknown to medicine.
X-linked hypophosphatemia is an early, growing map, so it will look incomplete on purpose: we would rather show less and have every line be something you can check than fill the page with claims we cannot stand behind.
For anything about your own situation, your clinicians hold the full picture.
How this guide is built and why.
Signs and symptoms
Spinal cord compression
Extra bone can form in the ligaments running along the spine in some people with this condition. Where it does, it can press on the spinal cord and damage it.
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesORPHA:89936
Notesplain_language confirmed from PMID:42065796 via curation 2026-07-27 [llm:fable-5]. | regrounded primary ORPHA:89936 -> PMID:42065796 on 2026-07-27 [Carrie Schluter, BCPA]
Last reviewed2026-07-27
Disproportionate short stature
In adults with X-linked hypophosphatemia the picture is one of severe, disproportionate short stature, marked skeletal deformity that makes walking difficult, pain in bones and joints, poor dental health, being overweight, and a reduced quality of life.
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesORPHA:89936
Notesplain_language confirmed from PMID:42429952 via curation 2026-07-27 [llm:fable-5]. | regrounded primary ORPHA:89936 -> PMID:42429952 on 2026-07-27 [Carrie Schluter, BCPA]
Last reviewed2026-07-27
Growth delay
Slowed growth is recorded significantly more often in people with this condition than in others, along with rickets, bowed legs, low blood phosphate, and calcium deposits in the kidneys.
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesORPHA:89936
Notesplain_language confirmed from PMID:38335127 via curation 2026-07-27 [llm:fable-5]. | regrounded primary ORPHA:89936 -> PMID:38335127 on 2026-07-27 [Carrie Schluter, BCPA]
Last reviewed2026-07-27
Secondary hyperparathyroidism
The parathyroid glands can become overactive in response to the condition, a change called secondary hyperparathyroidism. It was present in eight people in one group studied.
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesORPHA:89936
Notesplain_language confirmed from PMID:40852855 via curation 2026-07-27 [llm:fable-5]. | regrounded primary ORPHA:89936 -> PMID:40852855 on 2026-07-27 [Carrie Schluter, BCPA]
Last reviewed2026-07-27
Elevated circulating fibroblast growth factor 23 concentration
X-linked hypophosphatemia comes from changes in the PHEX gene, which raise the level of a hormone called fibroblast growth factor 23, or FGF23, circulating in the blood.
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesORPHA:89936
Notesplain_language confirmed from PMID:41777640 via curation 2026-07-27 [llm:fable-5]. | regrounded primary ORPHA:89936 -> PMID:41777640 on 2026-07-27 [Carrie Schluter, BCPA]
Last reviewed2026-07-27
Arthralgia
Joint pain becomes more common with age in this condition. In one large group it affected around one in eight of those aged 11 or under, and about seven in ten of those aged 50 or over.
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesORPHA:89936
Notesplain_language confirmed from PMID:40358789 via curation 2026-07-27 [llm:fable-5]. | regrounded primary ORPHA:89936 -> PMID:40358789 on 2026-07-27 [Carrie Schluter, BCPA]
Last reviewed2026-07-27
Renal phosphate wasting
In this group of inherited conditions the kidneys let too much phosphate escape into the urine instead of holding on to it. That loss of phosphate is the central problem.
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesORPHA:89936
Notesplain_language confirmed from PMID:41019664 via curation 2026-07-27 [llm:fable-5]. | regrounded primary ORPHA:89936 -> PMID:41019664 on 2026-07-27 [Carrie Schluter, BCPA]
Last reviewed2026-07-27
Craniosynostosis
Early fusion of the skull bones is one of the less well understood features of this condition, alongside dental abscesses, problems where tendons and ligaments attach to bone, and osteoarthritis.
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesORPHA:89936
Notesplain_language confirmed from PMID:40012305 via curation 2026-07-27 [llm:fable-5]. | regrounded primary ORPHA:89936 -> PMID:40012305 on 2026-07-27 [Carrie Schluter, BCPA]
Last reviewed2026-07-27
Muscle weakness
Muscle weakness is a typical feature, along with skeletal deformity, stiffness, and reduced physical function.
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesORPHA:89936
Notesplain_language confirmed from PMID:41185884 via curation 2026-07-27 [llm:fable-5]. plain_language confirmed from PMID:41185884 via curation 2026-07-27 [llm:fable-5]. | regrounded primary ORPHA:89936 -> PMID:41185884 on 2026-07-27 [Carrie Schluter, BCPA]
Last reviewed2026-07-27
Arthritis
Osteoarthritis is recorded more often than expected in people with this condition before treatment, alongside fractures, tendon and ligament problems and narrowing of the spinal canal. These tend to become more common with age.
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesORPHA:89936
Notesplain_language confirmed from PMID:40358789 via curation 2026-07-27 [llm:fable-5]. | regrounded primary ORPHA:89936 -> PMID:40358789 on 2026-07-27 [Carrie Schluter, BCPA]
Last reviewed2026-07-27
Generalized osteosclerosis
Bone throughout the body becomes denser than normal in X-linked hypophosphatemia. This includes thickening of the petrous bone in the skull and narrowing of the ear canal.
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesORPHA:89936
Notesplain_language confirmed from PMID:41445554 via curation 2026-07-27 [llm:fable-5]. | regrounded primary ORPHA:89936 -> PMID:41445554 on 2026-07-27 [Carrie Schluter, BCPA]
Last reviewed2026-07-27
Rickets
Raised FGF23 makes the kidneys hold on to less phosphate and produce less active vitamin D. In children that leads to rickets and impaired growth, and in both children and adults to osteomalacia, meaning softened bone.
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesORPHA:89936
Notesplain_language confirmed from PMID:41777640 via curation 2026-07-27 [llm:fable-5]. plain_language confirmed from PMID:41777640 via curation 2026-07-27 [llm:fable-5]. | regrounded primary ORPHA:89936 -> PMID:41777640 on 2026-07-27 [Carrie Schluter, BCPA]
Last reviewed2026-07-27
Treatment and management
What the research describes, not a recommendation. Treatment decisions belong with your clinician.
This covers treatments that appear in the published research mapped here. Investigational and experimental therapies are not included, so their absence is a boundary of this map, not a sign they do not exist.
burosumab
Burosumab is the recommended first-line treatment for X-linked hypophosphatemia, in children aged 1 to 17 and in adults.
Used to help with: X-linked hypophosphatemia.
The source text this rests on
“Although burosumab is now the recommended first-line treatment for XLH patients, both between 1 and 17 years old and adults, its continuous use is often limited by strict eligibility criteria, and adequate follow-up of XLH patients is difficult to maintain during the critical transition period from pediatric age to adulthood.”
An excerpt quoted verbatim from the source named above, shown as recorded. The full sentence is in the linked source.
Evidence ratingweak
Confidence (0-1)0.7
Replicationunreplicated
Notesconfirmed from PMID:41057893 via curation 2026-07-27
Last reviewed2026-07-27
How to read the evidence labels
Widely acceptedSpecialists broadly agree on this.
Strong evidenceBacked by solid, repeated research.
Moderate evidenceReasonable evidence, still being confirmed.
Limited evidenceSome evidence, but not yet convincing.
Early evidenceAn early finding that needs more study.
Experts disagreeResearchers actively disagree about this.
No longer supportedLater, stronger evidence or guidance overturned this.